| 000 | 01673 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518091727.0 | ||
| 264 | 0 | _c20211203 | |
| 008 | 202112s 0 0 eng d | ||
| 022 | _a1755-3245 | ||
| 024 | 7 |
_a10.1093/cvr/cvaa052 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRademaker, Miriam T | |
| 245 | 0 | 0 |
_aNatriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure. _h[electronic resource] |
| 260 |
_bCardiovascular research _c01 2021 |
||
| 300 |
_a508-519 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAldosterone _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtrial Natriuretic Factor _xblood |
| 650 | 0 | 4 |
_aCyclic GMP _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDiuresis _xdrug effects |
| 650 | 0 | 4 |
_aDiuretics _xpharmacology |
| 650 | 0 | 4 |
_aEndothelin-1 _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aNatriuresis _xdrug effects |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
| 650 | 0 | 4 |
_aRenin _xblood |
| 650 | 0 | 4 | _aSheep, Domestic |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 700 | 1 | _aScott, Nicola J A | |
| 700 | 1 | _aKoh, Cho Yeow | |
| 700 | 1 | _aKini, R Manjunatha | |
| 700 | 1 | _aRichards, A Mark | |
| 773 | 0 |
_tCardiovascular research _gvol. 117 _gno. 2 _gp. 508-519 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cvr/cvaa052 _zAvailable from publisher's website |
| 999 |
_c30737863 _d30737863 |
||